Johnson & Johnson, the worlds’ largest maker of health care products, has announced that its first-quarter profits were down, but that its earnings nevertheless beat analysts’ estimates.
According to a story in The Star Ledger out of Newark, sales for the quarter rose to $17.5 billion, an increase of 8.5 percent from a year earlier, compared to the $17.46 billion that analysts were predicting.
The story notes that a long-running string of ...
continue reading...
A U.S. appeals court has sided with health care giant Johnson & Johnson – throwing out an earlier $482 million verdict in a patent infringement case, according to a story in the Newark Star Ledger.
A doctor had claimed Johnson & Johnson infringed on the patent for his invention, which used a permeable barrier to treat injured tissue. He claimed the company improperly used the technology for a type of stent ...
continue reading...
Bloomberg reports that Denmark-based vaginal mesh manufacturer Coloplast’s stock dropped the most in almost four years over concerns about lawsuits that patients injured by the implants have filed.
The story says a joint status conference is scheduled for lawsuits filed against vaginal mesh manufacturers including Coloplast, American Medical Systems Holdings Inc., CR Bard Inc. and Boston Scientific Corp.
The mesh implants are supposed to treat urinary incontinence and pelvic organ prolapse, which ...
continue reading...
A Los Angeles jury recently awarded $8.3 million in damages to a man who claimed he suffered metal poisoning from an artificial hip implant manufactured by Johnson & Johnson’s DePuy Orthopaedics division. That was the first of about 10,000 lawsuits over the hip implant to go to trial.
But America isn’t the only country where people are seeking redress after being ...
continue reading...
A column by local physician Christie Iverson, MD, in the Bismarck Tribune out of North Dakota describes pelvic organ prolapse. Iverson writes that the condition is basically what happens when a woman’s pelvic floor weakens and the vaginal walls protrude, or a weakened uterus descends into the vaginal canal.
According to Iverson, new technology for prolapse surgery known as sacrocolpopexy has made it possible for women to get it corrected “with ...
continue reading...
A judge recently ordered Johnson & Johnson’s Ethicon division to pay Irish health care products manufacturer Covidien $176.5 million in damages over a patent dispute, Bloomberg reports.
At the conclusion of a non-jury trial, U.S. District Judge Janet Bond Arterton in New Haven, Conn., ruled that Ethicon infringed three U.S. patents for ultrasonic surgical instruments owned by Covidien.
Ethicon recently suffered another multi-million setback, in the form of an $11.1 million jury ...
continue reading...
